Mengis Capital Management, Inc. Viatris Inc Transaction History
Mengis Capital Management, Inc.
- $487 Million
- Q2 2024
A detailed history of Mengis Capital Management, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Mengis Capital Management, Inc. holds 36,672 shares of VTRS stock, worth $426,128. This represents 0.08% of its overall portfolio holdings.
Number of Shares
36,672
Previous 38,496
4.74%
Holding current value
$426,128
Previous $409,000
4.89%
% of portfolio
0.08%
Previous 0.06%
Shares
13 transactions
Others Institutions Holding VTRS
# of Institutions
1,085Shares Held
970MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.63 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.08 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$722 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$669 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$660 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $14.1B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...